Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 295, Issue 1, 2008, Pages

  Looft Wilson, Robin C ^a   Ashley, Blair S ^a   Billig, Janelle E ^a   Wolfert, Madeline R ^a   Ambrecht, Lindsay A ^a   Bearden, Shawn E ^b  

^a Dept of Economics and Thomas Jefferson Program in Public Policy at the College of William and Mary   (United States)

^b Nucl Eng Idaho State University   (United States)

Author keywords

Endothelial nitric oxide synthase; Homocysteine; S1179; Vasodilation

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; ACETYLCHOLINE; NITRATE; NITRITE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DIET THERAPY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HYPERHOMOCYSTEINEMIA; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BLOOD; C57BL MOUSE; CHRONIC DISEASE; DIET; DRUG EFFECT; ENDOTHELIUM; ENZYME INDUCTION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; CHRONIC DISEASE; DIET; ENDOTHELIUM; ENZYME INDUCTION; HYPERHOMOCYSTEINEMIA; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; NITRATES; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; NITROPRUSSIDE; PHENYLEPHRINE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 50649101304     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00833.2007     Document Type: Article

References (31)

1. Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, Looft-Wilson R, Murata T, Salomone S, Shin HK, Ayata C, Moskowitz MA, Michel T, Sessa WC, Huang PL. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest 117: 1961-1967, 2007.
2. Bagi Z, Ungvari Z, Koller A. Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia: possible role of peroxynitrite. Arterioscler Thromb Vasc Biol 22: 28-33, 2002.
3. Bearden SE, Linn E, Ashley BS, and Looft-Wilson RC. Age-related changes in conducted vasodilation: effects of exercise training and role in functional hyperemia. Am J Physiol Regul Integr Comp Physiol 293: R1717-R1721, 2007.
4. Beverelli F, Bea ML, Puybasset L, Giudicelli JF, Berdeaux A. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform. Fundam Clin Pharmacol 11: 252-259, 1997.
5. Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol Cell Physiol 285: C499-C508, 2003.
6. Chataigneau T, Feletou M, Huang PL, Fishman MC, Duhault J, Vanhoutte PM. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 126: 219-226, 1999.
7. Clarke ZL, Moat SJ, Miller AL, Randall MD, Lewis MJ, Lang D. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia. Eur J Pharmacol 551: 92-97, 2006.
8. Dayal S, Arning E, Bottiglieri T, Boger RH, Sigmund CD, Faraci FM, Lentz SR. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 35: 1957-1962, 2004.
9. Dayal S, Lentz SR. ADMA and hyperhomocysteinemia. Vasc Med 10 Suppl 1: S27-S33, 2005.
10. Dayal S, Lentz SR. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals. Antioxid Redox Signal 9: 1899-1910, 2007.
11. De Vriese AS, Blom HJ, Heil SG, Mortier S, Kluijtmans LA, Van de Voorde J, Lameire NH. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation 109: 2331-2336, 2004.
12. Dora KA, Sandow SL, Gallagher NT, Takano H, Rummery NM, Hill CE, Garland CJ. Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. J Vasc Res 40: 480-490, 2003.
13. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 106: 483-491, 2000.
14. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
15. Harrington LS, Carrier MJ, Gallagher N, Gilroy D, Garland CJ, Mitchell JA. Elucidation of the temporal relationship between endothelial-derived NO and EDHF in mesenteric vessels. Am J Physiol Heart Circ Physiol 293: H1682-H1688, 2007.
16. Huang A, Sun D, Carroll MA, Jiang H, Smith CJ, Connetta JA, Falck JR, Shesely EG, Koller A, Kaley G. EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice. Am J Physiol Heart Circ Physiol 280: H2462-H2469, 2001.
17. Jiang X, Yang F, Tan H, Liao D, Bryan RM Jr, Randhawa JK, Rumbaut RE, Durante W, Schafer AI, Yang X, Wang H. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 25: 2515-2521, 2005.
18. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3: 1646-1654, 2005.
19. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, Faraci FM. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol 279: H970-H975, 2000.
20. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 98: 24-29, 1996.
21. Li N, Yi FX, Rute E, Zhang DX, Slocum GR, Zou AP. Effects of homocysteine on intracellular nitric oxide and superoxide levels in the renal arterial endothelium. Am J Physiol Heart Circ Physiol 283: H1237-H1243, 2002.
22. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337: 230-236, 1997.
23. Powers RW, Gandley RE, Lykins DL, Roberts JM. Moderate hyperhomocysteinemia decreases endothelial-dependent vasorelaxation in pregnant but not nonpregnant mice. Hypertension 44: 327-333, 2004.
24. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136: 1726S-1730S, 2006.
25. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270: 2693-2698, 1993.
26. Sessa WC. eNOS at a glance. J Cell Sci 117: 2427-2429, 2004.
27. Sun D, Huang A, Smith CJ, Stackpole CJ, Connetta JA, Shesely EG, Koller A, Kaley G. Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res 85: 288-293, 1999.
28. Symons JD, Rutledge JC, Simonsen U, Pattathu RA. Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate. Am J Physiol Heart Circ Physiol 290: H181-H191, 2006.
29. Ungvari Z, Pacher P, Rischak K, Szollar L, Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 19: 1899-1904, 1999.
30. Waldron GJ, Ding H, Lovren F, Kubes P, Triggle CR. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br J Pharmacol 128: 653-658, 1999.
31. Woo KS, Sanderson JE, Sun YY, Chook P, Cheung AS, Chan LT, Metreweli C, Lolin YI, Celermajer DS. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96: 2542-2544, 1997.